RSV in Florida: Hospitals prep for surge in respiratory illness
“I'm very confident that by next fall we'll have a vaccine for RSV,” said Dr. Bruce Rankin, medical director at Accel Research.
Stay updated with breaking news from Accel Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“I'm very confident that by next fall we'll have a vaccine for RSV,” said Dr. Bruce Rankin, medical director at Accel Research.
The medical director at Accel Research Sites in DeLand expects a shot for RSV to be available by the new year and a combination RSV, COVID and flu shot by next fall.
Moderna and Pfizer announced they could release a new vaccine to protect against the omicron variant within 100 days.
Moderna and Pfizer announced they could release a new vaccine to protect against the omicron variant within 100 days.
DeLand teens getting Novavax vaccines as part of trial Alexa Lorenzo, Adam Poulisse About 4.1 million young people ages 12 to 17 have got their first COVID-19 shot. The only shot they can get is the Pfizer vaccine. But tucked away in DeLand, dozens of children are getting the Novavax COVID-19 vaccine. It’s part of the company’s vaccine trial for 12- to 17-year-olds playing out at Accel Research in DeLand. “I just wanted it,” said 14-year-old volunteer Madison White. The Clermont teen has wanted the shot for a while, but her mom Allisa White said, “She asked me if she...